These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14668706)

  • 1. What every cardiologist should know about intravascular contrast.
    Brinker J
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S19-27. PubMed ID: 14668706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Design of contrast diagnostic agents for intravascular injection: from the first experiments to our days].
    Sergeev PV; Iudin AL; Poliaev IuA; Shimanovskiĭ NL
    Vestn Rentgenol Radiol; 2002; (1):48-61. PubMed ID: 12715451
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in cardiac and vascular diseases: correlation to high spatial resolution 3D contrast-enhanced MRA.
    Krishnam MS; Tomasian A; Lohan DG; Tran L; Finn JP; Ruehm SG
    Clin Radiol; 2008 Jul; 63(7):744-55. PubMed ID: 18555032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of contrast media on blood coagulation system].
    Sviridov NK
    Vestn Khir Im I I Grek; 1975 Mar; 114(3):133-4. PubMed ID: 1119023
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultrasound contrast agents: an overview.
    Cosgrove D
    Eur J Radiol; 2006 Dec; 60(3):324-30. PubMed ID: 16938418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.
    de Haën C; Anelli PL; Lorusso V; Morisetti A; Maggioni F; Zheng J; Uggeri F; Cavagna FM
    Invest Radiol; 2006 Mar; 41(3):279-91. PubMed ID: 16481911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiology consultation as a gatekeeper prior to cardiac multi-detector computed tomography scan.
    Roguin A; Abadi S; Ghersin E; Engel A; Beyar R; Rispler S
    Isr Med Assoc J; 2008 Oct; 10(10):702-6. PubMed ID: 19009950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of contrast media-induced nephrotoxicity after angiographic procedures.
    Morcos SK
    J Vasc Interv Radiol; 2005 Jan; 16(1):13-23. PubMed ID: 15640403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adverse effects of angiographic radiocontrast media.
    Westhoff-Bleck M; Bleck JS; Jost S
    Drug Saf; 1991; 6(1):28-36. PubMed ID: 2029351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basics of non-invasive angiography contrast-enhanced magnetic resonance angiography.
    Scheffler K
    JBR-BTR; 2003; 86(6):344-6. PubMed ID: 14748399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombogenic potential of nonionic contrast media?
    Fareed J; Walenga JM; Saravia GE; Moncada RM
    Radiology; 1990 Feb; 174(2):321-5. PubMed ID: 2296640
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiographic contrast agents: conventional and new media compared.
    Bettmann MA
    AJR Am J Roentgenol; 1982 Oct; 139(4):787-94. PubMed ID: 6812399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative evaluation of CH3-DTPA-Gd (NMS60) for contrast-enhanced magnetic resonance angiography.
    Bammer R; de Crespigny AJ; Howard D; Seri S; Hashiguchi Y; Nakatani A; Moseley ME
    Magn Reson Imaging; 2004 Jun; 22(5):619-24. PubMed ID: 15172054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of zinc in nephrotoxicity of contrast media used in imaging diagnostics of the cardiovascular system.
    Tubek S; Tubek I
    Biol Trace Elem Res; 2007; 117(1-3):1-5. PubMed ID: 17873387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of nonionic contrast agents in neuroangiography. A review of the literature and recommendations for clinical use.
    Latchaw RE
    Invest Radiol; 1993 Nov; 28 Suppl 5():S55-9; discussion S60-1. PubMed ID: 8282504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenic systemic fibrosis: history and epidemiology.
    Thomsen HS
    Radiol Clin North Am; 2009 Sep; 47(5):827-31, vi. PubMed ID: 19744597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
    Barile A; Sabatini M; Iannessi F; Di Cesare E; Splendiani A; Calvisi V; Masciocchi C
    Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon dioxide in angiography to reduce the risk of contrast-induced nephropathy.
    Hawkins IF; Cho KJ; Caridi JG
    Radiol Clin North Am; 2009 Sep; 47(5):813-25, v-vi. PubMed ID: 19744596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selection of contrast media: current status of understanding].
    Briguori C
    G Ital Cardiol (Rome); 2009 Feb; 10(2):79-87. PubMed ID: 19348144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodinated contrast media and contrast-induced nephropathy: is there a preferred cost-effective agent?
    Sharma SK
    J Invasive Cardiol; 2008 May; 20(5):245-8. PubMed ID: 18460711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.